HLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease

Clinical and Vaccine Immunology

Volumn 15, Issue 4, 2008, Pages 729-731

  Mahdi, Najat ^a   Al Ola, Khadija ^a   Al Subaie, Abeer M ^b   Ali, Muhallab E ^b   Al Irhayim, Zaid ^b   Al Irhayim, A Qader ^b   Almawi, Wassim Y ^b  

^a Salmaniya Medical Complex ^*  (Bahrain)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ALLELE; ARTICLE; BLOOD VESSEL OCCLUSION; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; THROMBOCYTE ACTIVATION;

ADOLESCENT; ALLELES; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; CHILD; CONSTRICTION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; ERYTHROCYTES, ABNORMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ISCHEMIA; MALE;

EID: 47149113839     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00425-07     Document Type: Article

References (23)

1. Adekile, A., M. Z. Haider, R. Marouf, and A. D. Adekile. 2005. HLA-DRB1 alleles in Hb SS patients with avascular necrosis of the femoral head. Am. J. Hematol. 79:8-10.
2. Alarif, L., O. Castro, M. Ofosu, G. Dunston, and R. B. Scott. 1986. HLA-B35 is associated with red cell alloimmunization in sickle cell disease. Clin. Immunol. Immunopathol. 38:178-183.
3. Al-Jenaidi, F. A., S. F. Wakim-Ghorayeb, A. Al-Abbasi, M. R. Arekat, N. Irani-Hakime, P. Najm, K. Al-Ola, A. A. Motala, and W. Y. Almawi. 2005. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab. 90:5104-5109.
4. Ataga, K. I., and E. P. Orringer. 2003. Hypercoagulability in sickle cell disease: a curious paradox. Am. J. Med. 115:721-728.
5. Belcher, J. D., P. H. Marker, J. P. Weber, R. P. Hebbel, and G. M. Vercellotti. 2000. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96:2451-2459.
6. Castro, V., F. L. Alberto, R. N. Costa, J. Lepikson-Neto, S. F. Gualandro, M. S. Figueiredo, J. M. Annichino-Bizzacchi, S. T. Saad, and F. F. Costa. 2004. Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang. 87:118-123.
7. Chiang, E. Y., and P. S. Frenette. 2005. Sickle cell vaso-occlusion. Hematol. Oncol. Clin. N. Am. 19:771-784.
8. Fawaz, N. A., L. Bashawery, I. Al-Sheikh, A. Qatari, S. S. Al-Othman, and W. Y. Almawi. 2004. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am. J. Hematol. 76:307-309.
9. Hoppe, C., W. Klitz, J. Noble, L. Vigil, E. Vichinsky, and L. Styles. 2003. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101:2865-2869.
10. Kutlar, A. 2005. Sickle cell disease: a multigenic perspective of a single gene disorder. Hematology 10(Suppl. 1):92-99.
11. Mohammed, A. M., F. Al-Hilli, K. V. Nadkarni, G. P. Bhagwat, and J. P. Bapat. 1992. Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann. Saudi Med. 12:536-539.
12. Mohammad, A. M., K. O. Ardati, and K. M. Bajakian. 1998. Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency. J. Trop. Pediatr. 44:70-72.
13. Montes, R. A., J. R. Eckman, L. L. Hsu, and T. M. Wick. 2002. Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion. Am. J. Hematol. 70:216-227.
14. Moreira Neto, F., D. M. Lourenco, M. A. Noguti, V. M. Morelli, I. C. Gil, A. C. Beltrao, and M. S. Figueiredo. 2006. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Braz. J. Med. Biol. Res. 39:1291-1295.
15. Ofosu, M. D., O. Castro, and L. Alarif. 1987. Sickle cell leg ulcers are associated with HLA-B35 and Cw4. Arch. Dermatol. 123:482-484.
16. Pawloski, J. R., D. T. Hess, and J. S. Stamler. 2005. Impaired vasodilation by red blood cells in sickle cell disease. Proc. Natl. Acad. Sci. USA 102:2531-2536.
17. Rahimi, Z., A. Vaisi-Raygani, R. L. Nagel, and A. Muniz. 11 July 2007. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden. J. Thromb. Thrombolysis [Epub ahead of print.] doi: 10.1007/s11239-007-0069-x.
18. Rasmussen, T. E., J. W. Hallett Jr., H. D. Tazelaar, V. M. Miller, S. Schulte, W. M. O'Fallon, and C. M. Weyand. 2002. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J. Vasc. Surg. 35:988-993.
19. Stinson, J., and B. Naser. 2003. Pain management in children with sickle cell disease. Paediatr. Drugs 5:229-241.
20. Styles, L. A., C. Hoppe, W. Klitz, E. Vichinsky, B. Lubin, and E. Trachtenberg. 2000. Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood 95:3562-3567.
21. Tamouza, R., M. G. Neonato, M. Busson, F. Marzais, R. Girot, D. Labie, J. Elion, and D. Charron. 2002. Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum. Immunol. 63:194-199.
22. Turhan, A., P. Jenab, P. Bruhns, J. V. Ravetch, B. S. Coller, and P. S. Frenette. 2004. Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. Blood 103:2397-2400.
23. Turhan, A., L. A. Weiss, N. Mohandas, B. S. Coller, and P. S. Frenette. 2002. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. USA 99:3047-3051.